Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
Posada García
Celia
C
Florez
Angeles
A
Pardavila
Raquel
R
Garcia-Cruz
Arancha
A
Amador
Lourders
L
Alvarez
Mónica
M
Alberte
Laura María
LM
Cruces
Manuel José
MJ
D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide; D004317:Doxorubicin; D005260:Female; D006801:Humans; D007866:Leg; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008942:Mitoxantrone; D011239:Prednisolone; D011241:Prednisone; D000069283:Rituximab; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D008942:Mitoxantrone; D011241:Prednisone